They demonstrated that both CD4+CD25-GITR+ and CD4+CD25+GITR+ T cells, regardless of the CD25 expression, could prevent the development of colitis, indicating CD4+CD25-GITR+ and CD4+CD25+GITR+ T cells can retain the regulatory function (56). This evidence concerns the gene TNFRSF18 and colitis.